September 2016 media hits

Public Citizen is mentioned, or its experts quoted, every day in print and broadcast media around the world. Below are links to some of the recent stories in which we have appeared.

Patient groups, with loyalties split, sidestep drug price debate

9/30/2016
The New York Times: Patient groups, with loyalties split, sidestep drug price debate - “It is a conflict of interest, because the interests of the pharmaceutical industry, from whom they are getting support, may be different from the interests of the patients,” said Dr. Michael Carome, the director of the Health Research Group at Public Citizen, a consumer advocacy group.

Groups urge accounting board to require more tax disclosures

9/30/2016
The Hill: Groups urge accounting board to require more tax disclosures by Naomi Jagoda - Groups are pressing the Financial Accounting Standards Board (FASB) to require companies to publicly disclose certain tax and financial information on a country-by-country basis. Such disclosure would result in companies providing "a complete picture of their offshore operations," groups including the AFL-CIO, the Financial Accountability and Corporate Transparency Coalition and Public Citizen said in a letter to FASB Friday.

How US regulators may be creating a panic around Deutsche Bank

9/30/2016
CNBC: How US regulators may be creating a panic around Deutsche Bank by Evelyn Cheng - Bartlett Naylor, a shareholder activist and a member of financial watchdog group Public Citizen, said the U.S. regulators should go after the individuals who misrepresented mortgage-backed securities rather than the entire bank. 

Why the $600 EpiPen Costs $69 in Britain

9/29/2016
Bloomberg: Why the $600 EpiPen Costs $69 in Britain by James Paton and Naomi Kresge - Mylan charges a sixth of American prices in other wealthy nations, showing that the EpiPen -- a decades-old adrenaline auto-injector that can be life-saving for people with severe allergies -- can be profitable at far lower prices, according to a Sept. 20 report from advocacy group Public Citizen.

Can Wells Fargo CEO Stumpf keep his job after giving up millions in pay?

9/28/2016
The Charlotte Observer: Can Wells Fargo CEO Stumpf keep his job after giving up millions in pay? by Deon Roberts and Rick Rothacker - Some critics Wednesday also targeted the bank’s board, packed with former CEOs and government officials, for not acting sooner to crack down on the accounts issue. The board has not announced any member resignations or other changes.“They have a board?” activist shareholder Bart Naylor joked Wednesday.

Lobbyist to Hill staff: Trust me, we have a good case

9/28/2016
Politico: Lobbyist to Hill staff: Trust me, we have a good case by Isaac Arnsdorf - Rep. Mark Pocan (D-Wis.) is asking colleagues to sign a letter urging President Barack Obama to take executive action to rein in drug prices, supported by groups including CREDO Action, Social Security Works, Public Citizen and Daily Kos.

Why patient advocacy groups are silent about high drug prices

9/28/2016
Becker’s Hospital Review: Why patient advocacy groups are silent about high drug prices by Mackenzie Bean - "It is a conflict of interest, because the interests of the pharmaceutical industry, from whom they are getting support, may be different from the interests of the patients," said Michael Carome, MD, director of the Health Research Group at Public Citizen, a Washington, D.C.-based consumer advocacy group.

New Rule Will Stop Many Nursing Homes From Stripping Residents Of Their Right To Sue

9/28/2016
Consumerist: New Rule Will Stop Many Nursing Homes From Stripping Residents Of Their Right To Sue by Chris Morran - Susan Harley, Deputy Director of Public Citizen’s Congress Watch Division claims that arbitration clauses can be used to prevent nursing home residents from filing lawsuits to seek compensation for fraud, abuse, or neglect, “forcing them instead to seek redress before corporate-friendly arbitrators, with hearings held in secret and few grounds permitted for appeal.”

Progressive Groups Press Clinton to Speak Out Against Lame-Duck TPP Vote

9/28/2016
Mother Jones: Progressive Groups Press Clinton to Speak Out Against Lame-Duck TPP Vote by Patrick Caldwell - Last month, eight groups including CREDO sent a letter to Clinton asking her to publicly oppose a lame-duck vote on the TPP. "It is now more important than ever that the country, the Congress, and President Obama hear specifically that you oppose a vote on the job-killing TPP after the election," read the letter, which was also signed by Communications Workers of America, Democracy for America, 350 Action, Demand Progress, Fight for the Future, Friends of the Earth Action, and Public Citizen.

FDA's Cancer-Drug Reviewers Often Join Industry Later: Study

9/27/2016
HealthDay: FDA's Cancer-Drug Reviewers Often Join Industry Later: Study by Karen Pallarito - According to Dr. Michael Carome, director of Public Citizen's health research group, "We've said for years ... that the FDA has grown too cozy with industry."

Death By Prescription

9/27/2016
U.S. News and World Report: Death By Prescription by Michael O. Schroeder - “Most people who are harmed by prescription drugs [are] taking the drug as prescribed,” says Dr. Michael Carome, director of the Health Research Group at the consumer watchdog Public Citizen.

Furor Over Drug Prices Puts Patient Advocacy Groups in Bind

9/27/2016
New York Times: Furor Over Drug Prices Puts Patient Advocacy Groups in Bind by Katie Thomas - “It is a conflict of interest, because the interests of the pharmaceutical industry, from whom they are getting support, may be different from the interests of the patients,” said Dr. Michael Carome, the director of the Health Research Group at Public Citizen, a consumer advocacy group.

Public Backlash Grows Against Proposed Ads In National Parks

9/27/2016
Consumerist: Public Backlash Grows Against Proposed Ads In National Parks by Mary Beth Quirk - “It’s disappointing that the NPS did not post these comments for public review,” said Kristen Strader, campaign coordinator for Public Citizen’s Commercial Alert program. “But the public has spoken loudly and clearly against corporate sponsorships in our parks. We urge the National Park Service to hear their voices and abandon this plan, so the parks will forever be places to appreciate nature and American history, unspoiled by commercialism.”

SCOTUS Plays Inside Baseball With Business This Term

9/26/2016
Bloomberg BNA: SCOTUS Plays Inside Baseball With Business This Term by Kimberly Strawbridge Robinson - The high court vacancy has caused the justices to take a “wait-and-see” approach in cases that are ideologically divisive, meaning that they aren't agreeing to hear many cases where they might split 4–4, Public Citizen Litigation Group's Scott L. Nelson, Washington, told Bloomberg BNA Sept. 14.

Pro-TPP Tech Group Says Opponents Want to ‘Revert to Regionalized Economies’

9/26/2016
The Morning Consult: Pro-TPP Tech Group Says Opponents Want to ‘Revert to Regionalized Economies’ by Ryan Rainey - The authors criticized arguments from groups like the Sierra Club, AFL-CIO and Public Citizen about how the trade accord deals with their focus issues.

Clean Power Plan good for consumers, investors

9/25/2016
Daily Herald: Clean Power Plan good for consumers, investors by David Kolata - That's why the Citizens Utility Board joined with other consumer advocates, including Consumers Union and Public Citizen, in filing a court brief supporting the Clean Power Plan and its benefits for ratepayers.

“McConnell Threatens Government Shutdown to Keep Dark Money Secret”

9/22/2016
Election Blog: “McConnell Threatens Government Shutdown to Keep Dark Money Secret” by Rick Hasen - Public Citizen release via email:  In the midst of a close national election, the Republican leadership in Congress is risking a government shutdown to keep corporate political spending in the dark – raising obvious questions about just how much dark money is flowing into Republican campaign coffers and whether Republicans in Congress are doing the bidding of their corporate donors instead of serving the American people.

U.S. Energy Regulator Examines Beefing Up Utility Merger Reviews

9/22/2016
Bloomberg BNA: U.S. Energy Regulator Examines Beefing Up Utility Merger Reviews by Jonathan Crawford - “This is a common sense reform” that the commission is considering, Tyson Slocum, Washington-based director of energy at consumer advocacy group Public Citizen, said by phone. “Any time FERC is improving the criteria used to assess a merger or acquisition it’s going to benefit consumers, because you’re forcing the companies to do a better job of proving that the transaction won’t result in market power.”

Wells Fargo Customers May Never See Their Day in Court, Experts Say

9/22/2016
NBC News: Wells Fargo Customers May Never See Their Day in Court, Experts Say by Martha White - "They're going to come up against that arbitration clause," said Amanda Werner, arbitration campaign manager for the Americans for Financial Reform and Public Citizen. "We see things like this all the time," she said.

FDA Approves First Drug To Treat Rare Form Of Muscular Dystrophy

9/19/2016
Kaiser Health News: FDA Approves First Drug To Treat Rare Form Of Muscular Dystrophy by Liz Szabo - Overruling the advisory committee shows “a disturbing disregard for the agency’s  legal standards for approving new drugs,” said Michael Carome, director of Public Citizen’s Health Research Group, a nonprofit that studies drug safety.

Peterson Institute: Trump’s trade proposals ‘horribly destructive’

9/19/2016
Politico: Peterson Institute: Trump’s trade proposals ‘horribly destructive’ by Adam Behsudi - Public Citizen’s Lori Wallach, the leading voice in the anti-TPP movement, commented that the White House “cheerleading event” included “Wall Streeter” Paulson, the “face of the global economic crisis,” and Kasich, a failed GOP presidential candidate who was able to win the Ohio primary only because of a campaign based on “more of the same corporate-boosting economic policies.”

Free-Trade Deals Are Making It Much Harder to Fight AIDS

9/19/2016
The Nation: Free-Trade Deals Are Making It Much Harder to Fight AIDS by Michelle Chen - According to Public Citizen’s analysis of the TPP, which the president seeks to push through Congress before leaving office, the proposed intellectual-property provisions could undermine existing international accords that curb drug-licensing policies.

Did the FDA set ‘a dangerous precedent’ with its latest drug approval?

9/19/2016
STAT News: Did the FDA set ‘a dangerous precedent’ with its latest drug approval? by Damian Garde - “I have never seen such an extraordinarily low level of evidence,” said Dr. Michael Carome, director of health research for the watchdog group Public Citizen. “The FDA decision is very disappointing and reflects that the leadership of the FDA caved in to political pressure.”

Pain pill industry gives $5.15 million to Illinois politicians

9/18/2016
Belleville News-Democrat: Pain pill industry gives $5.15 million to Illinois politicians by Joseph Bustos and Casey Bischel - The Pain Care Forum, a group of pharmaceutical companies and groups associated with them, made 3,545 contributions in the past 10 years to Illinois politicians. That’s compared to just three contributions by Public Citizen, a group that favors more prescription drug regulation, which spent just $1,891.

Obama Escalates Fight for Passage of TPP

9/16/2016
Bloomberg BNA: Obama Escalates Fight for Passage of TPP by Cheryl Bolen - Lori Wallach, director of Public Citizen's Global Trade Watch, a group that opposes the TPP, said in a statement that opposition in Congress is growing.

House committee launches investigation into Wells Fargo sales tactics

9/16/2016
The Los Angeles Times: House committee launches investigation into Wells Fargo sales tactics by Jim Puzzanghera - Friday, the public interest group Public Citizen said it had filed a shareholder resolution with Wells Fargo asking the board of directors to study whether the bank should be broken up because it is too large to be effectively managed.

Wells Fargo Facing Disclosure Questions Over ‘Phantom’ Sales Scandal

9/16/2016
Reuters: Wells Fargo Facing Disclosure Questions Over ‘Phantom’ Sales Scandal by Dan Freed and Ross Kerber - In another, activist investor Bart Naylor, a financial policy analyst for consumer advocacy group Public Citizen, said he has filed a shareholder resolution calling on the bank to study breaking up its business in the wake of the scandal.

FEC Republicans Kill Attempt to Block Foreign Money in U.S. Elections

9/16/2016
The Intercept: FEC Republicans Kill Attempt to Block Foreign Money in U.S. Elections by Jon Schwarz and Naomi LaChance - Craig Holman, government affairs lobbyist for the public interest organization Public Citizen, argues that the FEC’s current frequent stalemates are due to a 2008 realization by Sen. Mitch McConnell, R.-Ky., that “he could bring the enforcement of campaign finance laws largely to a halt by selecting Republican FEC commissioners hostile to campaign finance laws.”

With TPP on Ropes, It's Corporate Power vs. People Power on Capitol Hill

9/16/2016
Common Dreams: With TPP on Ropes, It's Corporate Power vs. People Power on Capitol Hill by Deirdre Fulton - Public Citizen's Lori Wallach argued earlier this month that GOP leaders are in fact "negotiating for changes to obtain even more corporate goodies—longer monopoly protections for pharmaceutical firms' high medicine prices, elimination of an exception protecting some tobacco regulations from TPP attack, and more."

Wells Fargo faces scrutiny over lack of sales scandal disclosure

9/16/2016
Reuters: Wells Fargo faces scrutiny over lack of sales scandal disclosure by Dan Freed and Ross Kerber - In another, activist investor Bart Naylor, a financial policy analyst for consumer advocacy group Public Citizen, said he has filed a shareholder resolution calling on the bank to study breaking up its business in the wake of the scandal.

Commentary: A Royal ‘EpiPain’

9/16/2016
Rivard Report: Commentary: A Royal ‘EpiPain’ by Hanna Oberhofer - “The weirdness of a generic drug company offering a generic version of its own branded but off-patent product is a signal that something is wrong,” Robert Weissman, president of the consumer group Public Citizen, said in a statement to the New York Times. “In short, today’s announcement is just one more convoluted mechanism to avoid plain talk, admit to price gouging, and just cut the price of EpiPen.”

Wells Fargo drumbeat grows louder. House launches investigation

9/16/2016
CNN Money: Wells Fargo drumbeat grows louder. House launches investigation by Matt Egan -  If Wells Fargo senior executives were truly in the dark, Warren also said that means "this is simply a bank that is too big to manage." That's precisely what activist group Public Citizen suggested in a shareholder resolution filed on Friday.

This Loophole Ends the Privacy of Social Security Numbers

9/15/2016
Bloomberg: This Loophole Ends the Privacy of Social Security Numbers by Noah Feldman - The test case was initiated by a Washington-based lawyer named Michael Tankersley, who is a member in good standing of the Maryland bar. He got legal help from the watchdog group Public Citizen, which among other things is interested in promoting privacy-rights litigation.

Reproductive Rights Advocates Oppose Colorado’s Single-Payer Health-Care Measure

9/15/2016
Rewire: Reproductive Rights Advocates Oppose Colorado’s Single-Payer Health-Care Measure by Jason Salzman - Endorsers of the single-payer initiative include the League of Women Voters of Colorado, Public Citizen, numerous local Democratic Party organizations, and other entities, according to the ColoradoCare website.

Activist Naylor calls on Wells Fargo to study breakup

9/15/2016
Reuters: Activist Naylor calls on Wells Fargo to study breakup by Ross Kerber - Naylor, a financial policy analyst for consumer advocacy group Public Citizen, has submitted similar measures at other large banks in recent years. His latest calls on Wells Fargo's directors to study "whether the divestiture of all non-core banking business segments would enhance shareholder value."

CFPB Solidifies Its Presence With Wells Fargo Fine

9/15/2016
Morning Consult: CFPB Solidifies Its Presence With Wells Fargo Fine by Tara Jeffries - “I think it gives the public another opportunity to see just how important the CFPB’s work is for consumers, and I think it’s going to embolden the CFPB to pursue just as aggressive enforcement measures in the future,” Amit Narang, regulatory policy advocate at the left-leaning advocacy group Public Citizen, told Morning Consult. “What Congress and policymakers should be doing is encouraging them to continue.”

Thanks, Wells Fargo, for being such a bunch of weasels

9/15/2016
Los Angeles Times: Thanks, Wells Fargo, for being such a bunch of weasels by David Lazarus - “The scope of the misconduct at Wells Fargo is breathtaking and demonstrates why our new consumer watchdog, the Consumer Financial Protection Bureau, is essential,” said Lisa Gilbert, director of Public Citizen's Congress Watch division.

Pfizer's hopes for Chantix up in smoke?

9/14/2016
BioPharma Dive: Pfizer's hopes for Chantix up in smoke? by Lisa LaMotta - The big pharma argues the warning on the label is a deterrent to use and limits market potential, even though the post-marketing study showed there may not be an increased risk. But critics of the drug, including the advocacy group Public Citizen, say the study is inadequate to remove the warning and that patients have the right to know the risks.

Justice Department is investigating Wells Fargo sales tactics

9/14/2016
Los Angeles Times: Justice Department is investigating Wells Fargo sales tactics by Del Quentin Wilber and Jim Puzzanghera - Bart Naylor, financial policy advocate for Public Citizen, a public interest group, said he welcomed news of a Justice Department investigation and that some higher-level employees needed to be held accountable.

FDA panel votes to remove serious warning from Pfizer’s smoking cessation pill

9/14/2016
STAT News: FDA panel votes to remove serious warning from Pfizer’s smoking cessation pill by Ed Silvermam - Sammy Almashat of Public Citizen, the consumer advocacy group, noted the study included composite outcomes of both serious and milder symptoms, including irritability and agitation, which normally occur in people who are trying to quit smoking.

Wednesday Is National Call-In Day To Stop the TPP

9/14/2016
Campaign for America’s Future: Wednesday Is National Call-In Day To Stop the TPP by Dave Johnson - Lori Wallach, director of Public Citizen's Global Trade Watch, explains in "TPP Is Not Dead, Unfortunately" that, unfortunately, TPP is not dead.

Hopkins asked to stop research involving residents working long hours

9/14/2016
Baltimore Sun: Hopkins asked to stop research involving residents working long hours by Andrea K. McDaniels - Public Citizen, a consumer advocacy group, and the American Medical Student Association said the study, called iCompare, is unethical because patients aren't aware they are part of the research and have not consented to participating. They also say working long shifts leaves residents tired and more prone to making medical errors.

Advocacy group to Penn: Stop study requiring some residents to work 28-hour shifts

9/14/2016
Philadelphia Business Journal: Advocacy group to Penn: Stop study requiring some residents to work 28-hour shifts by John George - Public Citizen on Tuesday asked the University of Pennsylvania to stop a study it is participating in that requires first-year medical residents to work shifts of more than 28 hours without sleep. Public Citizen opposes the study saying it is "highly unethical" and fails to comply with key requirements of Department of Health and Human Services regulations for the protection of human subjects.

IEEFA: 40% of Texas coal generation at risk for retirement

9/14/2016
Utility Dive: IEEFA: 40% of Texas coal generation at risk for retirement by Robert Walton - A new report released by Public Citizen and the Institute for Energy Economics and Financial Analysis (IEEFA) predicts seven of Texas' 19 coal plants are losing money — possibly to the tune of $160 million annually — and will likely be shuttered if wholesale power prices do not rebound.

Clinton, Trump face fresh scrutiny on ethics

9/13/2016
USA Today: Clinton, Trump face fresh scrutiny on ethics by Fredreka Schouten - Lisa Gilbert of the liberal-leaning watchdog group Public Citizen said she’s optimistic that the next president will follow Obama's lead. “It would be very hard from a public-relations vantage to roll back an executive order on ethics," she said.

Public Concerned About Relaxed Doctor-In-Training Work Shifts

9/13/2016
Forbes: Public Concerned About Relaxed Doctor-In-Training Work Shifts by Bruce Japsen - And Public Citizen and the American Medical Student Association say four in five Americans are with them in wanting to keep caps on resident work hours despite division in the medical community among surgeons, hospitals and physician educators about whether the caps improve care and patient safety.

Resident Physicians and Long Work Hours: CIR Responds to Public Poll

9/13/2016
CIR News: Resident Physicians and Long Work Hours: CIR Responds to Public Poll by Heather Appel - With the release of a report today by Public Citizen on the public’s deep concerns about extremely long work hours for resident physicians, the nation’s oldest and largest physicians’ union is renewing its appeal for commonsense reforms that will protect both residents and patients. 

Dakota Access fight reaches White House … literally

9/13/2016
Politico: Dakota Access fight reaches White House … literally by Anthony Adragna - Power plants representing more than 40 percent of Texas’s coal-fired generating capacity are uncompetitive or soon will be due to cheap natural gas and expanded renewables in the state, according to a new report from the think tank Institute for Energy Economics and Financial Analysis and the advocacy group Public Citizen.

Sleeping on the Job: Medical Residents Forced to Work Long Shifts

9/13/2016
EHS Today: Sleeping on the Job: Medical Residents Forced to Work Long Shifts by Stefanie Valentic - “Medical residents are not superhuman, and when they’re not getting sleep, they’re putting patients in harm’s way,” said Dr. Michael Carome, director, Public Citizen’s Health Research Group.

Regulatory reform bill advances in House

9/13/2016
The Hill: Regulatory reform bill advances in House by Lydia Wheeler - "This bill makes our government agencies less transparent and limits their ability to reach the public through social media outlets like twitter,” Amit Narang, a regulatory policy advocate at Public Citizen, said in an email to The Hill.

Judge Hints Could Remand Disclosure Case to FEC

9/13/2016
Bloomberg BNA: Judge Hints Could Remand Disclosure Case to FEC by Kenneth P. Doyle - None of these ongoing court cases has yet resulted in a decision, though one is farther along than CREW's case involving enforcement action against AAN and AJS. That case, which was filed by the liberal nonprofit Public Citizen, involves the FEC's dismissal of an enforcement action against the conservative nonprofit Crossroads GPS, which is linked to prominent Republican political adviser Karl Rove.

Wells Fargo fired 5,300 workers for improper sales push. The executive in charge is retiring with $125 million

9/13/2016
Washington Post: Wells Fargo fired 5,300 workers for improper sales push. The executive in charge is retiring with $125 million by Renae Merle - "There are two possibilities: Customer abuse was part of business model, in which case lots of high ranking people need to go to prison," said Bart Naylor, a financial policy advocate for Public Citizen. "Or the bank is too big to manage, and folks high up don’t even know that laws are being broken a few levels down."

Survey Says: Don't Lift Limits on Residents' Hours

9/13/2016
MedPage Today: Survey Says: Don't Lift Limits on Residents' Hours by Shannon Firth - "Our basic take-home message today is that now is not the time for the ACGME to backtrack and allow resident physicians to work longer hours,"said Michael Carome, MD, director of the health research group for Public Citizen, which released the poll results during a press briefing on Tuesday.

Report: Seven Texas Coal Plants Could Close in Coming Years

9/12/2016
The Texas Observer: Report: Seven Texas Coal Plants Could Close in Coming Years by Naveena Sadasivam - Some plants are likely to lose hundreds of millions of dollars, Public Citizen says.

Protecting Online Access to Safe and Affordable Medication

9/12/2016
CircleID: Protecting Online Access to Safe and Affordable Medication by Gabriel Levitt - Global access to medicines advocates disagree with NABP's standard. For example, Peter Maybarduk, JD, the Director of Public Citizen's Access to Medicines Project, wrote in opposition to NABP's application: “Consumer access to medicines depends in significant part on price and competition. It would be inappropriate to allow NABP to control such an important gTLD while it maintains exclusionary plans for the domain, which work against the consumer interest in a robust marketplace of quality and affordable pharmaceuticals.”

House Passes Bill Outlawing “Gag Clauses” That Try To Punish Customers For Writing Negative Reviews

9/12/2016
Consumerist: House Passes Bill Outlawing “Gag Clauses” That Try To Punish Customers For Writing Negative Reviews by Chris Morran - Attorney Paul Alan Levy from Public Citizen, who was involved in both the KlearGear and Texas petsitter cases, tells Consumerist that the passing of the Fairness Act is great news for the consumer, “but it is also good news for businesses that do not need to paint a false picture of themselves by suppressing truthful criticisms in order to secure more customer, and for business harmed by competition from those businesses that do need to paint a fraudulent picture of themselves by using non-disparagement clauses.”

This Could Save Medicare at Least $16 Billion a Year, but the Agency Is Barred From Doing It

9/11/2016
The Motley Fool: This Could Save Medicare at Least $16 Billion a Year, but the Agency Is Barred From Doing It by Sean Williamm - Based on a study conducted by Carleton University and Public Citizen, Medicare could save $16 billion annually based on the $70 billion spent on prescription drugs in 2013. 

Senators Question Mylan CEO Over EpiPen Pricing, Generic Plans

9/11/2016
Bloomberg News: Senators Question Mylan CEO Over EpiPen Pricing, Generic Plans by Ronald Becker - Public Citizen, the watchdog group, has said the drug is still overpriced considering the fact that it is required by a number of people.

Conservatives Say Hillary Clinton Can’t Plead Ignorance—but Corporate Criminals Can

9/9/2016
New Republic: Conservatives Say Hillary Clinton Can’t Plead Ignorance—but Corporate Criminals Can by David Dayen - Robert Weissman of Public Citizen pointed out in testimony before the Senate Judiciary Committee in January that racketeering, conspiracy, the misbranding of food or medical devices, and mail and wire fraud all lack this specific standard.

The National Traffic and Motor Vehicle Safety Acts - Fiftieth Anniversary (1966-2016)

9/9/2016
PR Newswire: The National Traffic and Motor Vehicle Safety Acts - Fiftieth Anniversary (1966-2016) by Ralph Nader - Nader went on to found a wide variety of organizations, all aimed at advancing corporate and government accountability. Nader-inspired groups include Public Citizen, the Center for Auto Safety, the Center for Science in the Public Interest, the Clean Water Action Project, the Pension Rights Center, the Princeton Alumni Corps, and the Appleseed Foundation—a nonprofit network of 17 public interest justice centers.

Practice Rounds: CMS Announces Flexibility for MACRA

9/9/2016
Physicians Practice: Practice Rounds: CMS Announces Flexibility for MACRA by Gabriel Perna - Public Citizen, a nonprofit advocacy group, is working to change a loophole that allows providers to not have to report to the National Practitioner Data Base (NPDB).

Leading Economists Oppose TPP Provision Giving Corporations Upper Hand in Investor-State Disputes

9/8/2016
Democracy Now!: Leading Economists Oppose TPP Provision Giving Corporations Upper Hand in Investor-State Disputes - "Democracy Now!" speaks with Lori Wallach, director of Public Citizen’s Global Trade Watch. "This is an agreement so repugnant that members of Congress do not want to vote for it," says Lori Wallach.

Executive Overreach or Prosecutorial Discretion? Congress Debates 'Slush Funds'

9/8/2016
NPR affiliate WVTF: Executive Overreach or Prosecutorial Discretion? Congress Debates 'Slush Funds' by Michael Pope - Sonia Gill at Public Citizen says the bill is a cynical attack, “The proponents of this bill are essentially using it as a bully pulpit to attack what they term so-called activist groups, and I think that’s quite shameful.”

Consumer groups want FTC to crack down on celebrity endorsements

9/8/2016
ConsumerAffairs.com: Consumer groups want FTC to crack down on celebrity endorsements by James R. Hood - “Reality TV stars, actors and celebrities are often idolized, especially by young girls whose spending power and networks of followers attract companies that use undisclosed associations to prey upon insecurities by pushing beauty and health-related products,” said Kristen Strader, campaign manager for Public Citizen’s Commercial Alert.

Obama Promises Lame-Duck TPP Push Despite Uproar Over Pro-Corporate Provisions

9/8/2016
The Intercept: Obama Promises Lame-Duck TPP Push Despite Uproar Over Pro-Corporate Provisions by Zaid Jilani - If these provisions are included in TPP, the number of foreign investors who’d be empowered to use this mechanism would double from what we currently have in our 50 agreements already,” said Melinda St. Louis, international campaigns director at Public Citizen’s Global Trade Watch.

The case for how TPP, with fixes, could happen

9/8/2016
Politico: The case for how TPP, with fixes, could happen by Megan Cassell - "Giving foreign corporations special rights to challenge laws outside of the legal system is a bad deal to everyone except those corporations," Warren said on the call, organized by the anti-TPP activist group Public Citizen.

Warren ramping up opposition to Pacific trade deal

9/7/2016
The Hill: Warren ramping up opposition to Pacific trade deal by Vicki Needham - Public Citizen, which spearheaded the media call, said their research shows that the TPP includes nations with more than 9,000 corporate subsidiaries in the United States, which would double the exposure of the United States to ISDS lawsuits.

FTC Urged To Investigate Celebrity Endorsements On Instagram

9/7/2016
MediaPost: FTC Urged To Investigate Celebrity Endorsements On Instagram by Wendy Davis - Public Citizen and the other groups point to cosmetics and weight loss companies as major offenders. "The 'influencers' in this case are overwhelmingly reality TV stars idolized by young girls and teens, a demographic especially susceptible to advertising preying off of unrealistic standards of beauty," the organizations say.

Prominent Scholars Decry TPP's "Frontal Attack" on Law and Democracy

9/7/2016
Common Dreams: Prominent Scholars Decry TPP's "Frontal Attack" on Law and Democracy by Deirdre Fulton - As Public Citizen's Lori Wallach wrote last week, statements such as McConnell's need to be understood for what they are: negotiating for changes to obtain even more corporate goodies—longer monopoly protections for pharmaceutical firms' high medicine prices, elimination of an exception protecting some tobacco regulations from TPP attack, and more.

FERC oversight role at stake in DC Circuit hearing over ISO-NE power auction

9/7/2016
Utility Dive: FERC oversight role at stake in DC Circuit hearing over ISO-NE power auction by Robert Walton - The D.C. Circuit Court of Appeals yesterday heard oral arguments in Public Citizen v. Federal Energy Regulatory Commission, where consumer advocates are making the case that federal regulators should have blocked implementation of rates set in a 2014 auction, Greenwire reports.

Advocacy group aims to close malpractice loophole in NPDB

9/7/2016
Modern Medicine: Advocacy group aims to close malpractice loophole in NPDB by Keith Loria - Michael Carome, MD, director of Public Citizen’s Health Research Group, notes NPDB rules are not consistent with the federal statute that established the NPDB and that this “corporate shield” loophole undermines the accountability of physicians and the safety of patients.

Mylan’s Generic EpiPen — A Price Break Or Marketing Maneuver?

9/7/2016
Kaiser Health News: Mylan’s Generic EpiPen — A Price Break Or Marketing Maneuver? by Julie Appleby - Robert Weissman, president of the consumer group Public Citizen, said the generic price was still too high, writing in the Huffington Post of “the weirdness of a drug company offering a generic version” of its own brand-name product.

For Warren and her allies, a fight over Clinton’s hires

9/6/2016
Politico: For Warren and her allies, a fight over Clinton’s hires by Patrick Temple-West - Fifteen progressive groups, including Green’s, sent a letter to Clinton earlier in August calling for her to end the “revolving door” career path for people coming into regulatory roles from corporate America. According to the letter, also signed by such groups as Public Citizen and the Communications Workers of America, Clinton had pledged to consult with Warren on financial regulatory appointments.

Congress is back with WRDA, energy, approps on tap

9/6/2016
Politico: Congress is back with WRDA, energy, approps on tap by Eric Wolff - Public Citizen and the state of Connecticut are suing FERC over its decision not to investigate the 2014 auction's questionable results. D.C. Circuit Judges Janice Rogers Brown, Sri Srinivasan, and Robert Wilkins are hearing the case, 14-1244, in the E. Barrett Prettyman Courthouse.

Put the Midnight Boogeyman to Bed

9/6/2016
U.S. News and World Report: Put the Midnight Boogeyman to Bed by Lisa Gilbert - A new report released in July by Public Citizen demolishes the case against so-called "midnight regulations" – public protections issued in the final weeks and months of a presidential administration.

EpiPen maker feels heat from Congress

9/5/2016
The Hill: EpiPen maker feels heat from Congress by Megan R. Wilson - The release of a generic epinephrine auto-injector “is just one more convoluted mechanism for Mylan executives to avoid plain talk, admit their price gouging and just cut the price of EpiPen,” said Robert Weissman, the president of Public Citizen, in a statement.

EpiPen Controversy Continues

9/3/2016
MedPage Today: EpiPen Controversy Continues by Joyce Frieden - Consumer advocacy group Public Citizen also got into the act, delivering on Aug. 30th a petition signed by more than 700,000 people to Mylan's headquarters near Pittsburgh. The petition demanded an immediate reduction in the price of EpiPens. "We are here today because of corporate greed," Rick Claypool, a researcher at Public Citizen, said during the petition event, noting that the company makes $1 billion a year from EpiPens alone.

FDA Seeks Input on Drug, Device Off-Label Communications

9/2/2016
Bloomberg BNA: FDA Seeks Input on Drug, Device Off-Label Communications by Dana A. Elfin - “It is tremendously important that the FDA strongly regulate manufacturer communications regarding unapproved uses of approved or cleared medical products to protect public health,” Michael Carome, director of Public Citizen's Health Research Group, told Bloomberg BNA Aug. 31.

Litigation might redefine FERC's reach on power prices

9/2/2016
E&E News: Litigation might redefine FERC's reach on power prices by Amanda Reilly - "This is a case with some very serious implications about what we see as structurally uncompetitive electricity markets and the ability of very, very sophisticated, savvy financial interests to exploit these poorly designed market constructs — and FERC's duty to review all of these," said Tyson Slocum, director of Public Citizen's energy program.

Obama Takes Troubled Trade Portfolio to Asia

9/2/2016
Roll Call: Obama Takes Troubled Trade Portfolio to Asia by Ellyn Ferguson and Hugh T. Ferguson - Lori Wallach, director of Public Citizen’s Global Trade Watch, said the Obama administration has gotten public clarifications from several TPP countries that they will honor eight years of data exclusivity for biologic medical products.

Donald Trump’s Latest Hire Shows He’s No Different Than His Old Republican Foes

9/2/2016
The Huffington Post: Donald Trump’s Latest Hire Shows He’s No Different Than His Old Republican Foes by Paul Blumenthal - “It does paint Donald Trump’s campaign as not being friendly to campaign finance reform,” said Craig Holman, a government affairs lobbyist for the pro-campaign finance reform group Public Citizen.

Experts poke holes in Clinton Foundation's promised donor ban

9/1/2016
The Hill: Experts poke holes in Clinton Foundation's promised donor ban by Jonathan Swan - Craig Holman, government affairs lobbyist for the non-partisan watchdog Public Citizen, echoed Noble's concerns. "It just isn't going to sit well with the public if it starts becoming exposed that a 501(c) [non-profit entity] is making huge contributions, and then later we can figure out that 501(c) has actually been set up by Saudi Arabia," he said.